Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPATA13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | WDR35 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SERPINE2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | RBM15 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | SLC2A6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | CYP3A7-CYP3A51P | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | PAGE2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | REEP5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |